NLM Logo

Imatinib Mesylate MeSH Descriptor Data 2021


MeSH Heading
Imatinib Mesylate
Tree Number(s)
D02.065.277.456
D02.241.223.100.100.435
D02.455.426.559.389.127.085.465
D03.383.606.405
D03.383.742.349
Unique ID
D000068877
RDF Unique Identifier
http://id.nlm.nih.gov/mesh/D000068877
Scope Note
A tyrosine kinase inhibitor and ANTINEOPLASTIC AGENT that inhibits the BCR-ABL kinase created by chromosome rearrangements in CHRONIC MYELOID LEUKEMIA and ACUTE LYMPHOBLASTIC LEUKEMIA, as well as PDG-derived tyrosine kinases that are overexpressed in gastrointestinal stromal tumors.
Entry Term(s)
Alpha-(4-methyl-1-piperazinyl)-3'-((4-(3-pyridyl)-2-pyrimidinyl)amino)-p-tolu-p-toluidide
CGP 57148
CGP-57148
CGP57148B
Gleevec
Glivec
Imatinib
Imatinib Methanesulfonate
ST 1571
ST1571
STI 571
STI-571
STI571
Pharm Action
Antineoplastic Agents
Protein Kinase Inhibitors
Registry Number
8A1O1M485B
Related Numbers
220127-57-1
BKJ8M8G5HI
Public MeSH Note
2016; IMATINIB MESYLATE was indexed under BENZAMIDES, PIPERAZINES, and PYRIMIDINES 1996-2015
History Note
2016 (1996)
Date Established
2016/01/01
Date of Entry
2015/07/09
Revision Date
2016/05/31
Imatinib Mesylate Preferred
STI571 Narrower
Gleevec Narrower
ST 1571 Narrower
CGP 57148 Narrower
Imatinib Broader
page delivered in 0.164s